1040
Corrections
JACC Vol. 62, No. 11, 2013
September 10, 2013:1039–40
http://dx.doi.org/10.1016/j.jacc.2013.07.003
CORRECTION
Anderson JL, Adams CD, Antman EM, et al., “2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA
2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction: A
Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice
Guidelines,” (J Am Coll Cardiol. 2013;61:e179–e347. http://dx.doi.org/10.1016/j.jac.2013.01.014).
1. In Section 3.2.2. Anticoagulant Therapy: Recommendations (page e223), Class I, Recommendation 1a read, “a. For
patients in whom an invasive strategy is selected . . . (Figure 7; Box B1), and those with established efficacy . . .
JACC Vol. 62, No. 11, 2013
September 10, 2013:1039–41
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
Corrections
1041
(Figure 7; Box B1).” It has been changed to read, “a. For patients in whom an invasive strategy . . . (Appendix 9 has
replaced Figure 7), and those with established efficacy . . . (Appendix 9 has replaced Figure 7).”
In Section 3.2.2. Anticoagulant Therapy: Recommendations (page e223), Class I Recommendation 1b read, “b. For
patients in whom a conservative strategy . . . . (Figure 8; Box C1). . . .” It has been changed to read, “b. For patients in
whom a conservative strategy . . . . (Appendix 9 has replaced Figure 8) . . . .”
In Section 3.2.2. Anticoagulant Therapy: Recommendations (page e223), Class I Recommendation 1c read, “c. In
patients in whom a conservative strategy. . . fondaparinux is preferable. (Level of Evidence: B) (Figure 8; Box C1)” It
has been changed to read, “c. In patients in whom a conservative strategy. . . fondaparinux is preferable. (Level of
Evidence: B” (Appendix 9 has replaced Figure 8)”
In Section 3.2.2. Anticoagulant Therapy: Recommendations (page e223), Figure 7 has been deleted and the legend
changed to read, “Figure 7. Algorithm for . . . DeleteddNot Current. Replaced by Appendix 9.”
In Section 3.2.2. Anticoagulant Therapy: Recommendations (page e223), Figure 8 has been deleted and the legend
changed to read, “Figure 8. Algorithm for . . . . DeleteddNot Current. Replaced by Appendix 9.”
On page e223, Figure 9 has been deleted and the legend changed to read, “Figure 9. Management After Diagnostic
. . . . DeleteddNot Current. Replaced by Appendix 9.”
On page e224, second column, first paragraph, the second sentence read “The intensity of treatment is tailored . . .
(Appendixes 6 and 9; Figures 7, 8, and 9). . . .” It has been changed to read, “The intensity of treatment is tailored . . .
(Appendix 6; Appendix 9 has replaced Figures 7, 8, and 9). . . .”
In Section 3.2.4.2. Adenosine Diphosphate Receptor Antagonists and Other Antiplatelet Agents, 12th paragraph
(page e235), the last sentence read, “Thus, it appears beneficial . . . (Figures 7, 8, and 9; and Appendix 9 for updated
algorithm incorporating newer P2Y12 receptor inhibitors).” It has been changed to read, “Thus, it appears beneficial . . .
(Appendix 9 has replaced Figures 7, 8, and 9).”
In Section 3.2.4.2. Adenosine Diphosphate Receptor Antagonists and Other Antiplatelet Agents, 13th paragraph
(page e235), the second sentence read, “However, based on the early separation . . . (Figures 7, 8, and 9; and Appendix
9 for updated algorithm incorporating newer P2Y12 receptor inhibitors).” It has been changed to read, “However,
based on the early separation . . . (Appendix 9 has replaced Figures 7, 8, and 9).”
In Section 3.2.4.2. Adenosine Diphosphate Receptor Antagonists and Other Antiplatelet Agents, 17th paragraph
(page e235), the third sentence read, “However, unstable patients should receive. . . . (Figures 7, 8, and 9; and
Appendix 9 for updated algorithm incorporating newer P2Y12 receptor inhibitors).” It has been changed to read,
“However, unstable patients should receive). . . . (Appendix 9 has replaced Figures 7, 8, and 9).”
In Section 3.2.5. Anticoagulant Agents and Trials, third paragraph (page e236), the first sentence read “The 2007
Writing Committee believes that a number of acceptable anticoagulant strategies . . . (Figures 7, 8, and 9; and
Appendix 9 for updated algorithm incorporating newer P2Y12 receptor inhibitors).” It has been changed to read, “The
2007 Writing Committee believes that a number of acceptable anticoagulant strategies. . . (Appendix 9 has replaced
Figures 7, 8, and 9).”
In Section 3.2.5.4 Anticoagulant Agents and Trials, second column, first paragraph (page e243), the second sentence
read, “The 2007 Writing Committee believes that this observation introduces a note of caution . . . (Figures 7, 8, and
9; and Appendix 9 for updated algorithm incorporating newer P2Y12 receptor inhibitors).” It has been changed to
read, “The 2007 Writing Committee believes that this observation introduces a note of caution . . . (Appendix 9 has
replaced Figures 7, 8, and 9).”
In Section 3.2.5.5. Factor Xa Inhibitors, third paragraph (page e245), the first sentence read, “Thus, fondaparinux is
another anticoagulant . . . as noted in Figures 7, 8, and 9 (see Appendix 9 for updated algorithm incorporating newer
P2Y12 receptor inhibitors).” It has been changed to read, “Thus, fondaparinux is another anticoagulant . . . (Appendix
9 has replaced Figures 7, 8, and 9).”
Section 3.3.1 Should be titled “General Principles.”
In Section 3.3.1. General Principles, first paragraph (page e252), the penultimate sentence read, “Even here,
appropriate medical therapy . . . (Figures 7, 8, and 9; and Appendix 9 for updated algorithm incorporating newer
P2Y12 receptor inhibitors).” It has been changed to read, “Even here, appropriate medical therapy . . . (Appendix 9 has
replaced Figures 7, 8, and 9).”
The title to Appendix 9 (page e347) read, “Flowchart for Class I and Class IIa Recommendations for Initial
Management of UA/NSTEMI (NEW).” It has been changed to read, “Flowchart for Class I and Class IIa
Recommendations for Initial Management of UA/NSTEMI (NEWd Replaces Figures 7, 8, and 9 in 2007
Guideline).”
In the last sentence of the Appendix 9 footnote (page e347), reference 1 should be cited instead of reference 7.
http://dx.doi.org/10.1016/j.jacc.2013.07.004